摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,3-Ethylenedioxy-1-p-toluenesulfonate | 15658-19-2

中文名称
——
中文别名
——
英文名称
3,3-Ethylenedioxy-1-p-toluenesulfonate
英文别名
2-(2-Methyl-1,3-dioxolan-2-yl)ethyl 4-methylbenzenesulfonate
3,3-Ethylenedioxy-1-p-toluenesulfonate化学式
CAS
15658-19-2
化学式
C13H18O5S
mdl
——
分子量
286.349
InChiKey
QMFMRPYBMIYCQT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    407.6±25.0 °C(Predicted)
  • 密度:
    1?+-.0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    70.2
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    3,3-Ethylenedioxy-1-p-toluenesulfonate 在 lithium bromide 作用下, 以 丙酮 为溶剂, 反应 3.0h, 生成 2-(2-溴乙基)-2-甲基-1,3-二恶茂烷
    参考文献:
    名称:
    Sokolov; Salfetnikova; Potekhin, Russian Journal of Organic Chemistry, 1996, vol. 32, # 6, p. 838 - 846
    摘要:
    DOI:
  • 作为产物:
    描述:
    methyl (2-methyl-1,3-dioxolan-2-yl)acetate吡啶 、 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 反应 18.0h, 生成 3,3-Ethylenedioxy-1-p-toluenesulfonate
    参考文献:
    名称:
    Potentiation of cADPR-Induced Ca2+-Release by Methylxanthine Analogues
    摘要:
    Caffeine and other methylxanthines are known to induce Ca2+-release from intracellular stores via the ryanodine receptor. In the present work, a range of caffeine analogues, in which methyl groups at the 1 and 7 positions were replaced with alkyl chains containing different functional groups (oxo, hydroxyl, propargyl, ester, and acids), were synthesized. These compounds were then screened for their ability to potentiate Ca2+-release induced by cADPR (an endogenous modulator of ryanodine receptors) in sea urchin egg homogenates. Two of the synthesized methylxanthines, 1,3-dimethyl-7-(7-hydroxyoctyl)xanthine (37) and 3-methyl-7-(7-oxooctyl)-1-propargylxanthine (66), were shown to be more potent than caffeine in potentiating cADPR-induced Ca2+-release, while 1,3-dimethyl-7-(5-ethylcarboxypentyl)xanthine (14) was shown to be more efficacious. The development of new methylxanthine analogues may lead to a better understanding of ryanodine receptor function and could possibly provide novel therapeutic agents.
    DOI:
    10.1021/jm980469t
点击查看最新优质反应信息

文献信息

  • CYCLIC COMPOUND, PHOTORESIST BASE MATERIAL AND PHOTORESIST COMPOSITION
    申请人:Shibata Mitsuru
    公开号:US20100190107A1
    公开(公告)日:2010-07-29
    A cyclic compound shown by the following formula (I):
    一个由以下公式(I)所示的环状化合物:
  • CALIXRESORCINARENE COMPOUND, PHOTORESIST BASE COMPRISING THE SAME, AND COMPOSITION THEREOF
    申请人:Watanabe, Takeo
    公开号:EP1886989A1
    公开(公告)日:2008-02-13
    A calixresorcinarene compound represented by the following formula (1): wherein eight Rs are n (n is an integer of 1 to 7) substituents that are one or more types of substituents selected from groups represented by the following formula (2), and m (m is an integer shown by 8-n) hydrogen atoms; and R's, which may be the same or different, are each a straight-chain aliphatic hydrocarbon group having 2 to 12 carbon atoms, a branched aliphatic hydrocarbon group having 3 to 12 carbon atoms, a phenyl group, a p-phenylphenyl group, a p-tert-butylphenyl group, and an aromatic group represented by the following formula (3), or a substituent formed by combining two or more of these substituents: wherein R" is a hydrogen atom or a substituent selected from the substituents represented by the formula (2).
    以下是一个由下式(1)表示的calixresorcinarene化合物: 其中,八个Rs是n(n是1到7的整数)取代基,是从以下式(2)所代表的基团中选择的一种或多种类型的取代基,m(m是8-n所示的整数)个氢原子;而R'可以相同也可以不同,每个都是具有2到12个碳原子的直链脂肪烃基,具有3到12个碳原子的支链脂肪烃基,苯基,p-苯基苯基,p-叔丁基苯基和由以下式(3)所代表的芳基或两个或更多这些取代基组合形成的取代基: 其中,R"是氢原子或从式(2)所代表的取代基中选择的取代基。
  • Approaches to the Synthesis of Triterpenoids. II. Some Tetracyclic Precursors Suitable for Conversion into Pentacyclic Triterpenoids
    作者:J. W. ApSimon、P. Baker、J. Buccini、J. W. Hooper、S. Macaulay
    DOI:10.1139/v72-309
    日期:1972.6.15
    The stereoselective total synthesis of several partially reduced chrysene derivatives, suitable as precursors for a variety of triterpenoids, is described. The key reaction in the most efficient route involves the highly stereoselective reductive alkylation of a cyclic α,β-unsaturated ketone with allyl bromide in lithium–ammonia, using water as a proton donor.
    描述了几种部分还原的 chrysene 衍生物的立体选择性全合成,这些衍生物适合作为各种三萜类化合物的前体。最有效路线中的关键反应涉及使用作为质子供体,在 - 中使用烯丙基对环状 α,β-不饱和酮进行高度立体选择性的还原烷基化。
  • ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE COMPOSITION, AND RESIST FILM, RESIST-COATED MASK BLANKS, RESIST PATTERN FORMING METHOD AND PHOTOMASK EACH USING THE COMPOSITION
    申请人:FUJIFILM CORPORATION
    公开号:US20150010855A1
    公开(公告)日:2015-01-08
    There is provided an actinic ray-sensitive or radiation-sensitive composition containing (α) a compound represented by the formula (αI) capable of generating an acid having a size of 200 Å 3 or more in volume and (β) a compound capable of generating an acid upon irradiation with an actinic ray or radiation, and the formula (αI) is defined as herein, and a resist film formed using the actinic ray-sensitive or radiation-sensitive composition, a resist-coated mask blanks coated with the resist film, a resist pattern forming method comprising exposing the resist film and developing the exposed film, a photomask obtained by exposing and developing the resist-coated mask blanks, a method for manufacturing an electronic device, comprising the resist pattern forming method and an electronic device manufactured by the manufacturing method of an electronic device.
    提供一种感光或辐射敏感的组合物,其中包含(α)一种化合物,其由公式(αI)表示,能够产生大小为200Å3或更大的体积的酸,以及(β)一种化合物,能够在受到光辐射或辐射时产生酸,公式(αI)的定义如本文所述。还提供了使用该感光或辐射敏感组合物形成的光阻膜,涂有光阻膜的光阻涂层掩模坯料,包括曝光光阻膜和显影曝光后膜的光阻图案形成方法,通过曝光和显影涂有光阻涂层的掩模坯料获得的光掩模,以及一种电子器件的制造方法,包括光阻图案形成方法和制造电子器件的电子器件制造方法,以及通过该电子器件制造方法制造的电子器件。
  • Keinan, Ehud; Sinha, Subhash C.; Sinha-Bagchi, Anjana, Journal of the Chemical Society. Perkin transactions I, 1991, # 12, p. 3333 - 3340
    作者:Keinan, Ehud、Sinha, Subhash C.、Sinha-Bagchi, Anjana
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫